Pharmaceuticals, Biotechnology and Life Sciences
ImmuPharma said Friday that 200 patients were recruited and dosed in its Phase III trial of Lupus drug Lupuzor. Furthermore, all 200 patients have passed the 3 months stage, with over 90% of patients (184) have passed 6 months.
N4 Pharma provided latest research results for its Nuvec nanoparticles which it is developing as a delivery system for DNA and mRNA vaccines and therapeutics.
About a quarter of countries in sub-Saharan Africa receive little funding for research into malaria despite having high death rates, according to a study on Thursday that highlighted the unequal spread of resources to tackle the disease.
Novartis and Merck have both surprised experts in the past week by finding new ways to tackle heart disease, although the jury remains out as to whether this scientific success will translate into blockbuster sales.
Drugstore chain Walgreens Boots Alliance Inc
AstraZeneca and Chi-Med said on Thursday they kicked off the third phase of clinical testing of their cancer drug.
Regular physical activity promotes general good health, reduces the risk of developing many diseases, and helps you live a longer and healthier life. For many of us, “exercise” means walking, jogging, treadmill work, or other activities that get the heart pumping.
BASF said Wednsesday it plans to build a new world-scale plant to produce ibuprofen in Ludwigshafen, Germany.
In a daily briefing, Daily Stock Tracker (DST) gave some insight on certain biotech stocks, noting that the global Pharmaceutical industry is dominated by the American and European markets. According to Forbes’ top companies of 2017, the ten biggest drug companies are all located in these two regions.
Arix Bioscience has raised $45 million by a Series B financing round for LogicBio Therapeutics, a new Arix Group Business focused on gene therapies for orphan paediatric diseases.